Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Monitoring and Predictive Models for Optimizing Monoclonal Antibody Therapy in Early Alzheimer's Disease - A Prospective Monocenter Interventional Study on 3T MRI

NCT07456462 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07456462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07456462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Monitoring and Predictive Models for Optimizing Monoclonal Antibody Therapy in Early Alzheimer's Disease - A Prospective Monocenter Interventional Study on 3T MRI
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
May 1, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia (ad), mild cognitive impairment (mci)